The Latest Breaking News from FDA

Consumer groups say it’s past time to rid food of unnecessary and potentially harmful chemicals

Imported tea was required for decades to pass a literal taste test before it could be sold in the United States.

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. Stocks this morning are moderately lower, with the Nasdaq 100 falling to a...

Though the drug only received FDA approval for the treatment of type 2 diabetes, these high-profile individuals have used it for weight loss. Some quit after a few weeks. The post These Celebrities Admitted To Taking Ozempic, And Some Had Terrible Side Effects first appeared on Bored Panda.

The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.

Filipino single mother Mary Ann Eduarte delayed chemotherapy for her breast cancer for several years and instead took food supplements falsely promoted on social media as cures for the deadly disease.

After a bumpy road, Madrigal gained FDA approval for the first-ever MASH treatment, Rezdiffra, and Madrigal stock skyrocketed.

Testing commissioned by Mamavation blog found high levels of a marker of PFAS in nine of 11 baggies tested

Shares of Recursion Pharmaceuticals offer solid upside potential, given the company's trailblazing approach to drug discovery leveraging AI. Here’s a closer look at the biotech stock that has garnered investments from both AI chipmaker Nvidia and ARKK fund manager Cathie Wood.